|
GRINL1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.391170E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.813900E-02 |
| Normal-vs-Stage2 |
2.951600E-01 |
| Normal-vs-Stage3 |
9.291400E-01 |
| Normal-vs-Stage4 |
8.147000E-01 |
| Stage1-vs-Stage2 |
8.520400E-01 |
| Stage1-vs-Stage3 |
2.665800E-02 |
| Stage1-vs-Stage4 |
6.987900E-02 |
| Stage2-vs-Stage3 |
2.568200E-01 |
| Stage2-vs-Stage4 |
2.442400E-01 |
| Stage3-vs-Stage4 |
8.767600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.066200E-01 |
| Normal-vs-AfricanAmerican |
5.012000E-02 |
| Normal-vs-Asian |
1.697580E-01 |
| Caucasian-vs-AfricanAmerican |
8.659500E-02 |
| Caucasian-vs-Asian |
4.814800E-01 |
| AfricanAmerican-vs-Asian |
3.008600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.209000E-01 |
| Normal-vs-Female |
8.588300E-02 |
| Male-vs-Female |
1.895590E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.048500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.010800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.071800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.644600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.046000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.721600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.718000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.334040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.142400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.581800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.056600E-03 |
| Classical-VS-Follicular |
5.063200E-01 |
| Classical-VS-Other |
5.368400E-01 |
| Classical-VS-Normal |
3.698000E-02 |
| Tall-VS-Follicular |
6.039500E-02 |
| Tall-VS-Other |
5.260800E-01 |
| Tall-VS-Normal |
3.246400E-01 |
| Follicular-VS-Other |
7.418600E-01 |
| Follicular-VS-Normal |
2.955000E-01 |
| Other-VS-Normal |
9.233600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.233600E-01 |
| Normal-vs-N1 |
9.837200E-01 |
| N0-vs-N1 |
3.383200E-01 |
|
|
